Learning the lessons of antitumour necrosis factor therapy-associated psoriasis

AUTOR(ES)

Shale, Matt

FONTE

Pulsus Group Inc

RESUMO

Psoriasis or psoriasiform skin lesions, as an adverse effect of treatment with antitumor necrosis factor antibody therapy, have been described relatively recently. Patients with these lesions have no personal or family history of psoriasis. In a small number of cases, an association with Chlamydia has been suggested. The skin lesions may disappear on discontinuation of therapy or, in the majority of cases, even if antitumor necrosis factor antibody therapy is continued. Therefore, withdrawal of therapy is generally not required for this adverse effect but referral to a dermatologist may be desirable for confirmation of diagnosis and treatment.

Documentos Relacionados

• Cisplatin therapy-associated recurrent toxic shock syndrome.
• In vivo assessment of antiretroviral therapy-associated side effects
• Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil
• Optic neuritis occurring with anti‐tumour necrosis factor α therapy
• Anti‐tumour necrosis factor α therapy in patients with impaired renal function